Unbound MEDLINE

An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine. Anesthesia and analgesia [Anesth Analg] Journal article

 
TitleAn exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine.
Author(s)Mason KP, Zgleszewski S, Forman RE, Stark C, DiNardo JA 
InstitutionDepartment of Anesthesia, Perioperative and Pain Medicine, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA. keira.mason@childrens.harvard.edu
SourceAnesth Analg 2009 Mar; 108(3):906-8.
AbstractAt our institution, high-dose i.v. dexmedetomidine is used to provide sedation for pediatric patients undergoing nonpainful radiological imaging studies. Some of these patients exhibit marked bradycardia (more than 20% deviation from the lowest age-adjusted normal values) while maintaining an arterial blood pressure within an acceptable normal range. We report on three cases wherein treatment of dexmedetomidine-induced bradycardia with i.v. glycopyrrolate (5.0 microg/kg) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
Languageeng
Pub Type(s)Journal Article
PubMed ID19224802
  
Advertise on this site.